U.S. Electronic Equipment and Components Stock News

Setting the Scene for Expedia Group Stock Expedia Group (EXPE) has drawn attention recently after a mix of short term share price swings and longer term returns that look very different depending on the timeframe investors focus on. See our latest analysis for Expedia Group. The recent 1 day and 7 day share price declines sit against a 30 day share price return of 10.83% and a 1 year total shareholder return of 35.42%. This suggests shorter term momentum has faded while longer term...

Wondering whether Cleveland-Cliffs at a last close of US$8.11 offers value or a value trap? This breakdown will help you frame the price against what the business may be worth. The stock has recently shown mixed performance, with a 3.7% gain over the last 7 days but declines of 24.8% over 30 days, 40.4% year to date, and 4.8% over the past year. These moves sit against a longer track record that shows 55.8% and 58.2% declines over the past 3 and 5 years respectively. This can influence how...

Why Par Pacific Holdings Is on Investor Radars Par Pacific Holdings (PARR) has drawn fresh attention after a strong recent run, with the stock showing double digit returns over the past month and the past 3 months. This performance is prompting closer scrutiny of its underlying business. See our latest analysis for Par Pacific Holdings. At a share price of $65.67, the stock has moved sharply in recent months, with an 83.33% year to date share price return and a very large 1 year total...

Summit Therapeutics presented new Phase III data on ivonescimab at the 2026 European Lung Cancer Congress in EGFR mutated NSCLC. The data highlighted improved intracranial progression free survival, including in patients with brain metastases. The company has submitted a Biologics License Application to the FDA, with a PDUFA decision date set for November. Summit Therapeutics, trading as NasdaqGM:SMMT, is drawing attention after sharing these late stage results alongside a confirmed FDA...

California Water Service Group (CWT) is back on watch after recent share price moves, with the stock showing mixed returns over the past year as investors reassess this regulated water utility. See our latest analysis for California Water Service Group. At a share price of $45.01, California Water Service Group has recently seen a 7 day share price return of 2.51% but the 1 year total shareholder return is a decline of 4.2%. This suggests that recent momentum contrasts with weaker longer term...

Recent share performance and business profile Rithm Capital (RITM) has drawn attention after a recent 1 day share price decline of 1.8%, following gains of 4.2% over the past week and negative returns over the past month and past 3 months. The company operates as an asset manager focused on real estate, credit, and financial services in the United States, with a market value of about US$5.2b and a last close of US$9.14 per share. See our latest analysis for Rithm Capital. That recent 1 day...

If you are wondering whether Solaris Energy Infrastructure at US$57.83 is still attractively priced after its run, this section is designed to help you frame that question clearly. The stock has seen a 6.4% decline over the past week, a 4.7% gain over the last 30 days, a 15.1% gain year to date, and a 156.2% gain over the last year, which may signal shifting views on both its potential and its risks. Recent attention on the company has focused on its role in energy infrastructure and how...

Earlier this month, OpenText released a global report with the Ponemon Institute on managing risks and optimizing the value of AI, generative AI, and agentic AI, highlighting that many enterprises have adopted these tools without fully developed security and governance frameworks. The study’s finding that only a small minority of enterprises fully embed AI into cybersecurity and risk assessment underlines a widening gap between AI deployment and risk management that could influence how...

Churchill Downs (CHDN) is back in focus after recent share price moves, with the stock closing at US$84.52 and showing negative returns over the past month, the past three months, and the past year. See our latest analysis for Churchill Downs. The recent 1 day share price return of 3.48% decline caps a tougher patch for Churchill Downs, with the 30 day share price return of 12.09% decline and 1 year total shareholder return of 23.72% decline, which together point to fading momentum despite...

SkyWater Technology: recent returns and business mix SkyWater Technology (SKYT) has attracted attention after a sharp move in its share price over the past year, with a 1 year total return above 200% and a past 3 months return near 50%. The company, valued at about US$1.34b and recently closing at US$27.00, reports US$442.139m in revenue and net income of US$118.91m, with operations split between its Legacy SkyWater and SkyWater Texas segments. See our latest analysis for SkyWater...

In March 2026, Credo Technology Group Holding settled its Active Electrical Cable patent disputes by entering license and cross-license agreements with Molex and TE Connectivity, leading to prompt dismissal of all related lawsuits under confidential terms. By removing the legal overhang around key AEC technology, Credo has clarified its IP position with major ecosystem players in high-speed connectivity. We’ll now examine how resolving patent disputes with Molex and TE Connectivity may...

Leadership change and why it matters for Amdocs (NasdaqGS:DOX) Amdocs (NasdaqGS:DOX) is in focus after Shuky Sheffer retired from both the management team and the Board, with Shimie Hortig taking over as President, Chief Executive Officer, and Board member. CEO transitions often prompt investors to reassess expectations around execution, capital allocation, and long term priorities, especially for a software and services business with a global communications and media customer base. See our...

Markel Group (NYSE:MKL) has appointed Phil Jones as Chief Information Officer, International. Jones brings technology and operational experience across insurance, financial services, and government sectors. The role covers Markel International’s digital capabilities, operational resilience, and service delivery. For investors watching NYSE:MKL, this move highlights the growing importance of technology leadership for insurance and specialty risk businesses. As underwriting, claims, and...

Oklahoma Gas and Electric Company, a subsidiary of OGE Energy (NYSE:OGE), announced a new fixed-income offering of callable senior and subordinated unsecured fixed rate notes. The notes are structured as unsecured obligations and include both senior and subordinated tranches, with fixed interest rates. The securities are callable, meaning the issuer may choose to redeem them before maturity, subject to the offering terms. OGE Energy, through Oklahoma Gas and Electric, operates as a...

Some investors may be considering whether Grindr's current share price reflects its potential value, or whether the market is mispricing the stock at present. Over the past month, Grindr's share price has moved by 11.3%, while the 1 year return shows a 29.8% decline. This may draw the attention of investors who are weighing recent momentum against longer term performance. Recent coverage around Grindr has focused on its position as a listed interactive media and services platform, including...

Earnings pressure and guidance keep the focus on GIS General Mills (GIS) has been under pressure after recent earnings showed lower sales and profits, while management reaffirmed guidance that points to continued margin headwinds and softer demand in the near term. See our latest analysis for General Mills. The recent earnings disappointment and cautious guidance have weighed heavily on sentiment, with the 30 day share price return of 18.16% and 1 year total shareholder return of 35.25% both...

BridgeBio Pharma has announced that long-term efficacy and safety results from the open-label extension of its Phase 3 ATTRibute-CM trial of acoramidis in ATTR-CM, including multiple analyses on survival, disease stabilization, and patient-reported outcomes, were presented at the American College of Cardiology Annual Scientific Sessions in New Orleans on March 28–30, 2026. The new data, alongside real-world survey findings on treatment patterns and preferences in ATTR-CM, offer a deeper view...

If you are wondering whether Global-E Online is starting to look attractive or still carries too much risk, its recent share price moves and current valuation metrics give you plenty to think about. The stock last closed at US$28.93, with returns of a 10.5% decline over 7 days, a 17.6% decline over 30 days, a 23.6% decline year to date and an 18.9% decline over 1 year. These moves may have shifted how the market is pricing its prospects and risks. These moves have come as Global-E Online...

Why Stagwell’s HarrisQuest Expansion Matters for Investors Stagwell (STGW) recently expanded The Harris Poll’s HarrisQuest platform across Europe, giving regional brands access to always on, data driven brand and reputation tracking that global companies already use for key marketing decisions. See our latest analysis for Stagwell. Stagwell’s recent HarrisQuest expansion and focus on artificial intelligence backed services comes as the shares trade at US$6.08, with a 30 day share price return...

H.B. Fuller (NYSE:FUL) secured key raw materials after more than 40 force majeure notices linked to Middle East related supply disruptions. The company plans a minimum 10% global price increase effective April 1, 2026, to address inflation and raw material cost pressures. Management has paused acquisitions to focus on debt reduction and share buybacks, which signals a shift in capital allocation priorities. For investors watching NYSE:FUL, the share price sits at $59.17, with a 20.0% gain...

In March 2026, Alteogen announced an exclusive license deal giving Biogen rights to develop subcutaneous formulations for two biologic products using ALT-B4 Hybrozyme technology, while new data from Eisai and Biogen showed strong long-term real-world treatment persistence for intravenous lecanemab in Alzheimer’s patients. Together, these developments highlight Biogen’s push to expand patient-friendly biologic delivery and deepen its presence in Alzheimer’s care through therapies patients are...

Recently, RingCentral reported solid quarterly results, but weaker billings and softer demand indicators have raised fresh questions about the strength of its underlying growth engine. An unusual red flag is the negative customer acquisition cost payback period, suggesting current sales and marketing spending may not be efficiently converting into profitable, long-term customers. Next, we'll explore how concerns over weak billings and soft demand could reshape RingCentral's existing...

Herbalife (HLF) is back on investors' radar after recent share price pressure, with the stock showing a 25.2% decline over the past month following an earlier 8.1% gain in the past 3 months. See our latest analysis for Herbalife. At a share price of $14.41, Herbalife’s recent 1 month share price return of a 25.2% decline contrasts with a 12.4% year to date share price gain and a 68.14% 1 year total shareholder return. This suggests that momentum has recently faded after a stronger run. If...

Why Danaher (DHR) Is Drawing Attention Now Danaher (DHR) is back on many watchlists after a period of weaker share performance, including a 13% decline over the past month and a 21% decline over the past 3 months. See our latest analysis for Danaher. At a share price of $181.52, Danaher’s recent 13% 1 month share price decline and 21% 3 month share price decline extend a tougher run, while the 1 year total shareholder return of 11% and 5 year total shareholder return of 7% indicate pressure...